Compare BVS & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BVS | INMD |
|---|---|---|
| Founded | 2011 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 716.8M | 842.0M |
| IPO Year | 2016 | 2018 |
| Metric | BVS | INMD |
|---|---|---|
| Price | $9.50 | $14.79 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 5 |
| Target Price | $14.00 | ★ $17.33 |
| AVG Volume (30 Days) | ★ 653.3K | 605.2K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 163.46 | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $568,087,000.00 | N/A |
| Revenue This Year | $7.52 | $1.74 |
| Revenue Next Year | $7.06 | $3.26 |
| P/E Ratio | $232.25 | ★ $10.11 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.81 | $12.72 |
| 52 Week High | $11.25 | $16.74 |
| Indicator | BVS | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 56.20 | 69.74 |
| Support Level | $8.43 | $14.58 |
| Resistance Level | $11.00 | $15.33 |
| Average True Range (ATR) | 0.37 | 0.22 |
| MACD | 0.11 | 0.08 |
| Stochastic Oscillator | 79.41 | 76.77 |
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.